Beranda › Kanker Saluran Empedu (Kolangiokarsinoma)
Uji klinis Kanker Saluran Empedu (Kolangiokarsinoma) yang merekrut di AS
56 studi untuk Kanker Saluran Empedu (Kolangiokarsinoma) merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX13 studi
- New York City, NY11 studi
- Boston, MA8 studi
- Rochester, MN7 studi
- Arlington, VA7 studi
- Los Angeles, CA7 studi
- Chicago, IL7 studi
- Columbus, OH6 studi
- Cleveland, OH6 studi
- Edison, NJ5 studi
- Queens, NY5 studi
- Grand Rapids, MI5 studi
- Nashville, TN5 studi
- San Antonio, TX5 studi
- Philadelphia, PA5 studi
- Tampa, FL5 studi
- Mountain View, CA5 studi
- Washington, DC5 studi
- Baldwin Park, CA5 studi
- Baltimore, MD5 studi
- Dallas, TX5 studi
- Miami, FL5 studi
- Orange, CA4 studi
- St. Louis, MO4 studi
- Durham, NC4 studi
- Seattle, WA4 studi
- Detroit, MI4 studi
- New Haven, CT4 studi
- Atlanta, GA3 studi
- West Valley City, UT3 studi
- Jacksonville, FL3 studi
- Salt Lake City, UT3 studi
- Buffalo, NY3 studi
- Birmingham, AL3 studi
- San Francisco, CA3 studi
- Louisville, KY3 studi
- Santa Monica, CA3 studi
Berdasarkan negara bagian
- Alabama3 studi
- Arizona3 studi
- California20 studi
- Colorado3 studi
- Connecticut6 studi
- Florida13 studi
- Georgia3 studi
- Illinois8 studi
- Kentucky4 studi
- Maryland9 studi
- Massachusetts10 studi
- Michigan8 studi
- Minnesota10 studi
- Missouri5 studi
- New Jersey8 studi
- New York15 studi
- North Carolina6 studi
- Ohio10 studi
- Pennsylvania5 studi
- Tennessee5 studi
- Texas15 studi
- Utah6 studi
- Virginia10 studi
- Washington4 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06728410Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT03942328Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Menerima pesertaStudi observasional
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT01915225A Study of PHST001 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06270706Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04645160PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Menerima pesertaFase 2
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05286814A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07265674[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07673341Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06302621Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Menerima pesertaFase 2
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07146646A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07780838Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05732831Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07282912Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07619313Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07486713TCR1188-ABC Cells in KRAS-mutated Cancers
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07594067Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT05285358D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT06622057Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.